Company: MDCXW
Filing Date: 2025-04-30
Form Type: 10-K/A
Source: 0001062993-25-008246
Chunk: 15

Company: Medicus Pharma Ltd.
Filing Date: 2025-04-30
Form: 10-K/A
Chunk 15
---
. 11

| Name               |     | Year |     | Option-Based 
      Awards- 
 Value Vested 
   During the 
      Year(1) |     | Share-Based 
 Awards -    
 Value       
 Vested      
 During the  
 Year        |     | Non-Equity     
 Incentive Plan 
 Compensation   
 - Value        
 Earned         
 During the     
 Year           |
|                    |     |      |     |           -$ |     | -$          |     | -$             |
| Dr. Raza Bokhari   |     | 2024 |     |      100,856 |     | -           |     | -              |
| James Quinlan      |     | 2024 |     |       40,342 |     | -           |     | -              |
| Dr. Edward Brennan |     | 2024 |     |       40,342 |     | -           |     | -              |

Notes: (1)Reflects the aggregate dollar value that would have been realized if the options had been exercised on the vesting date, calculated based on the difference between the market price of the underlying securities at exercise and the exercise price of the options on the vesting date. Pension Plan Benefits The Company does not have a pension plan in place and therefore no pension plan benefit awards were made to a director or named executive officer during the financial year ended December 31, 2024. Termination and Change of Control Benefits The termination benefits and change of control benefits for the named executive officers are described under the heading "-Employment and Consulting Agreements with Executive Officers" and under the heading "Security Based Compensation Plan-Summary of the Equity Incentive Plan-Termination of Employment or Service" and "Security Based Compensation Plan -Summary of the Equity Incentive Plan-Change of Control" below. Oversight and Description of Named Executive Officer Compensation The Company's Compensation Committee is responsible for the oversight of executive officer compensation. The Compensation Committee has established an executive compensation program, which includes equity compensation under the Equity Incentive Plan, and the other elements of compensation described herein. In the performance of its duties, the Compensation Committee is expected to be focused on offering competitive compensation to attract, retain and motivate the best qualified executives for the Company to meet its goals while acting in the interests of the Company and its stakeholders, including but not limited to its shareholders, and pursing these objectives in a manner that is fiscally responsible. Philosophy and Objectives The compensation program